The Company has enclosed herewith Certificates received from RTA under regulation 7(45) of SEBI DP Regulations, 2018 for the quarter ended 31.06.2025
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krebs Biochemicals has submitted compliance certificates received from its Registrar and Share Transfer Agent, KFIN Technologies, under SEBI Regulation 74(5) for the quarter ended 30 June 2025. These certificates were issued separately to both CDSL and NSDL confirming that details of securities dematerialized and rematerialized during the quarter have been furnished to the stock exchanges where the company is listed (BSE and NSE). This is a routine quarterly compliance requirement mandated by SEBI for companies whose shares are held in dematerialized form.
This is a routine regulatory compliance filing with no impact on the company's operations, financials, or stock price. It simply confirms that the company's share transfer records are in order for the quarter.